Clinic
Bedford Stuyvesant Family Health Center, INC.
Bedford Stuyvesant Family Health Center, INC. was paid $20.51M by Medicaid between Jan 2018 and Dec 2024, across 196 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoBEDFORD STUYVESANT FAMILY HEALTH CENTER, INC.
BROOKLYN, NY 11216
BROOKLYN, NY 11216
33aNPI1033178561assigned 03/22/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$20.51M
24GClaims801,972
24DCodes billed196
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in New York
Rank by total paid#21 of 158
Median peer was paid$1.73M
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 109,666 | $3.44M | |
| 2019 | 109,854 | $2.68M | |
| 2020 | 101,339 | $2.84M | |
| 2021 | 138,467 | $3.61M | |
| 2022 | 123,700 | $2.29M | |
| 2023 | 122,154 | $2.74M | |
| 2024incomplete | 96,792 | $2.91M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 134,536 | 79,604 | $9.33M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 30,090 | 19,815 | $2.08M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.5% | 20,789 | 13,224 | $1.55M |
| D1110 | Prophylaxis - adult | 2.7% | 8,845 | 6,255 | $545K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.6% | 7,734 | 5,156 | $529K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 2.4% | 25,204 | 7,248 | $498K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.3% | 6,541 | 4,296 | $473K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.9% | 5,491 | 3,634 | $392K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.8% | 4,890 | 3,589 | $378K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.8% | 4,813 | 3,507 | $369K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.8% | 4,937 | 2,339 | $366K |
| D0150 | Comprehensive oral evaluation - new or established patient | 1.5% | 16,453 | 4,344 | $310K |
184 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,724 | $200K |
| 99442 | <1% | 3,638 | $196K | |
| D0330 | Panoramic radiographic image | <1% | 8,000 | $189K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 2,837 | $175K |
| D0140 | Limited oral evaluation - problem focused | <1% | 4,916 | $171K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,009 | $169K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,615 | $159K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 10,652 | $139K |
| D0274 | Bitewings - four radiographic images | <1% | 7,139 | $128K |
| 99443 | <1% | 1,442 | $121K | |
| 99493 | <1% | 1,081 | $116K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,771 | $111K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 10,358 | $100K |
| 92551 | <1% | 21,235 | $98K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,344 | $94K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 1,868 | $94K |
| 99441 | <1% | 1,565 | $91K | |
| 97803 | <1% | 1,276 | $84K | |
| 11765 | <1% | 1,006 | $76K | |
| 92015 | Determination of refractive state | <1% | 2,427 | $75K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,012 | $75K |
| 97802 | <1% | 1,626 | $72K | |
| 99497 | <1% | 2,083 | $67K | |
| 99490 | Ccm add 20min | <1% | 580 | $62K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 608 | $51K |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 7,091 | $48K |
| 36415 | Collection of venous blood by venipuncture | <1% | 40,080 | $44K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 533 | $42K |
| 99385 | <1% | 469 | $37K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 4,798 | $36K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,840 | $35K |
| 90682 | <1% | 662 | $32K | |
| T2022 | Case management, per month | <1% | 465 | $30K |
| D1120 | Dental cleaning, child | <1% | 710 | $28K |
| 11721 | <1% | 1,531 | $27K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 349 | $25K |
| 99173 | <1% | 17,917 | $25K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 2,441 | $22K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 209 | $20K |
| 82948 | <1% | 10,217 | $20K | |
| 86780 | <1% | 1,775 | $18K | |
| 90461 | <1% | 2,526 | $17K | |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 216 | $16K |
| D2140 | <1% | 230 | $14K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 195 | $11K |
| 90686 | <1% | 3,494 | $11K | |
| 83718 | <1% | 3,018 | $11K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 115 | $10K |
| D9110 | <1% | 523 | $10K | |
| H0049 | Alcohol and/or drug screening | <1% | 11,331 | $9K |
| D0180 | <1% | 267 | $8K | |
| 0001F | <1% | 74,042 | $8K | |
| D4355 | <1% | 316 | $8K | |
| 0011A | <1% | 382 | $8K | |
| 81025 | <1% | 1,544 | $8K | |
| 99492 | <1% | 66 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 891 | $7K |
| 99000 | <1% | 14,103 | $6K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 87 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 762 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 273 | $5K |
| 90656 | <1% | 667 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 270 | $5K |
| 86769 | <1% | 143 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 251 | $4K |
| 11056 | <1% | 298 | $4K | |
| D0190 | <1% | 114 | $4K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 332 | $4K |
| 94150 | <1% | 1,549 | $4K | |
| 99408 | <1% | 1,098 | $4K | |
| 99401 | <1% | 94 | $4K | |
| 87481 | <1% | 299 | $4K | |
| D4341 | <1% | 56 | $3K | |
| 92134 | <1% | 119 | $3K | |
| 81513 | <1% | 342 | $3K | |
| S9449 | Weight management classes, non-physician provider, per session | <1% | 22,161 | $3K |
| A4614 | Peak expiratory flow rate meter, hand held | <1% | 213 | $3K |
| 99386 | <1% | 37 | $3K | |
| 90651 | <1% | 534 | $3K | |
| 0012A | <1% | 117 | $3K | |
| 90736 | <1% | 25 | $2K | |
| 92250 | <1% | 98 | $2K | |
| 99381 | <1% | 24 | $2K | |
| 99384 | <1% | 37 | $2K | |
| 90863 | <1% | 201 | $2K | |
| 99406 | <1% | 240 | $2K | |
| 93000 | <1% | 275 | $2K | |
| 2022F | <1% | 724 | $2K | |
| 3008F | <1% | 83,379 | $2K | |
| 90802 | <1% | 22 | $1K | |
| 86580 | <1% | 218 | $1K | |
| 99201 | <1% | 19 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 38 | $1K |
| 91322 | <1% | 17 | $1K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 27 | $984.58 |
| S9451 | Exercise classes, non-physician provider, per session | <1% | 20,193 | $950.23 |
| 1125F | <1% | 7,505 | $839.73 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 94 | $592.01 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 90 | $550.46 |
| 90670 | <1% | 293 | $522.37 | |
| D0270 | <1% | 70 | $513.50 | |
| S8110 | Peak expiratory flow rate (physician services) | <1% | 500 | $469.51 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 41 | $452.95 |
| 90480 | <1% | 14 | $307.03 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 17 | $300.65 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 14 | $256.73 |
| 81002 | <1% | 106 | $250.94 | |
| 99407 | <1% | 13 | $250.27 | |
| 90474 | <1% | 62 | $240.18 | |
| 90710 | <1% | 122 | $225.11 | |
| 3074F | <1% | 255 | $225.00 | |
| 3078F | <1% | 209 | $222.50 | |
| 91301 | <1% | 402 | $217.49 | |
| 90715 | <1% | 39 | $216.87 | |
| 1126F | <1% | 7,323 | $210.75 | |
| 88150 | <1% | 25 | $192.73 | |
| 90734 | <1% | 281 | $123.45 | |
| D0272 | Bitewings - two radiographic images | <1% | 12 | $109.12 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 8,508 | $99.74 |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 198 | $84.61 |
| 1159F | <1% | 9,728 | $62.00 | |
| 96161 | <1% | 159 | $61.94 | |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | <1% | 9,407 | $53.68 |
| 92227 | <1% | 12 | $27.32 | |
| 3079F | <1% | 31 | $20.00 | |
| 90633 | <1% | 128 | $15.11 | |
| H0009 | Alcohol and/or drug services; acute detoxification (hospital inpatient) | <1% | 18 | $14.80 |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | <1% | 2,052 | $11.65 |
| 99496 | <1% | 12 | $10.00 | |
| 86703 | <1% | 1,995 | $8.10 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 6,171 | $3.96 |
| 1111F | <1% | 1,418 | $1.72 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 13,206 | $1.26 |
| 83655 | <1% | 150 | $1.06 | |
| G0451 | Development testing, with interpretation and report, per standardized instrument form | <1% | 218 | $0.23 |
| 86706 | <1% | 56 | $0.22 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 6,322 | $0.20 |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 53 | $0.16 |
| 87110 | <1% | 15 | $0.11 | |
| 87536 | <1% | 27 | $0.09 | |
| 86803 | <1% | 12 | $0.07 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 14 | $0.07 |
| 90648 | <1% | 123 | $0.06 | |
| 90657 | <1% | 13 | $0.03 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 931 | $0.02 |
| G8783 | Normal blood pressure reading documented, follow-up not required | <1% | 4,875 | $0.02 |
| S9453 | Smoking cessation classes, non-physician provider, per session | <1% | 59 | $0.01 |
| 4015F | 0% | 293 | $0.00 | |
| 1036F | 0% | 2,476 | $0.00 | |
| 1034F | 0% | 26 | $0.00 | |
| 1220F | 0% | 362 | $0.00 | |
| 1030F | 0% | 73 | $0.00 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 15 | $0.00 |
| 90732 | 0% | 121 | $0.00 | |
| 1038F | 0% | 303 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 951 | $0.00 |
| 1170F | 0% | 51 | $0.00 | |
| 1000F | 0% | 831 | $0.00 | |
| 1005F | 0% | 347 | $0.00 | |
| 90680 | 0% | 76 | $0.00 | |
| 90696 | 0% | 51 | $0.00 | |
| 99495 | 0% | 12 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 16 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 13 | $0.00 |
| D0601 | 0% | 13 | $0.00 | |
| 1035F | 0% | 13 | $0.00 | |
| 1123F | 0% | 13 | $0.00 | |
| 4037F | 0% | 60 | $0.00 | |
| 4000F | 0% | 13 | $0.00 | |
| 90723 | 0% | 15 | $0.00 | |
| A9152 | Single vitamin/mineral/trace element, oral, per dose, not otherwise specified | 0% | 15 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 17 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 139 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 669 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 2,132 | $0.00 |
| 3725F | 0% | 1,137 | $0.00 | |
| 4551F | 0% | 50 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 469 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 29 | $0.00 |
| 1160F | 0% | 111 | $0.00 | |
| 1039F | 0% | 293 | $0.00 | |
| 1158F | 0% | 424 | $0.00 | |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 98 | $0.00 |
| 4001F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABDUR-RAHMAN, NURAH JAHAN (CREDENTIALING COORDINATOR)